Farapulse

Device BOSTON SCIENTIFIC CORPORATION
Total Payments
$6.9M
Transactions
876
Doctors
12
Companies
2

Payment Trends by Year

Year Amount Transactions Doctors
2024 $107,359 10 1
2023 $1.1M 246 4
2022 $3.7M 495 9
2021 $2.1M 125 11

Payments by Nature

Nature of Payment Amount Transactions Share
Unspecified $6.5M 812 95.0%
Consulting Fee $237,009 53 3.4%
Long term medical supply or device loan $106,959 9 1.6%
Food and Beverage $108.49 2 0.0%

Payments by Type

Research
$6.5M
812 transactions
General
$344,077
64 transactions

Research Studies & Clinical Trials

Study Name Sponsor Amount Doctors
ADVENT BOSTON SCIENTIFIC CORPORATION $3.6M 0
Advent BOSTON SCIENTIFIC CORPORATION $1.7M 0
ADVENT Boston Scientific Corporation $1.0M 0
Advent Boston Scientific Corporation $260,171 0

Top Doctors Receiving Payments for Farapulse

Doctor Specialty Location Total Records
Unknown Nashville, TN $6.6M 821
, M.D Clinical Cardiac Electrophysiology New York, NY $55,507 3
, M.D Clinical Cardiac Electrophysiology Boston, MA $28,800 18
, M.D Clinical Cardiac Electrophysiology Philadelphia, PA $22,500 2
, M.D., PH.D Cardiovascular Disease Burlington, VT $22,130 7
, MD Cardiovascular Disease San Francisco, CA $21,292 7
, MD Cardiovascular Disease Indianapolis, IN $19,763 5
, MD Cardiovascular Disease San Francisco, CA $18,000 1
, MD Thoracic Surgery (Cardiothoracic Vascular Surgery) Dallas, TX $18,000 1
, M.D Cardiovascular Disease New York, NY $18,000 2
, MD Cardiovascular Disease Salt Lake City, UT $10,351 6
, M.D Hematology Rochester, MN $2,425 2
, MD Cardiovascular Disease Durham, NC $350.00 1

About Farapulse

Farapulse is a device associated with $6.9M in payments to 12 healthcare providers, recorded across 876 transactions in the CMS Open Payments database. The primary manufacturer is BOSTON SCIENTIFIC CORPORATION.

Payment data is available from 2021 to 2024. In 2024, $107,359 was paid across 10 transactions to 1 doctors.

The most common payment nature for Farapulse is "Unspecified" ($6.5M, 95.0% of total).

Farapulse is associated with 4 research studies, including "ADVENT" ($3.6M).